Swenson, Luke C <br/><br/>
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 2013 
 - 6122-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01534-13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>CCR5 Receptor Antagonists--therapeutic use<br/>Cyclohexanes--therapeutic use<br/>Female<br/>Gene Expression<br/>Genotype<br/>HIV Envelope Protein gp120--chemistry<br/>HIV Fusion Inhibitors--therapeutic use<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Male<br/>Maraviroc<br/>Middle Aged<br/>Peptide Fragments--chemistry<br/>Receptors, CCR5--genetics<br/>Receptors, CXCR4--genetics<br/>Treatment Failure<br/>Triazoles--therapeutic use<br/>Viral Tropism